TIDMBPCR

RNS Number : 8476G

BioPharma Credit PLC

21 July 2023

 
BIOPHARMA CREDIT PLC (the 'Company') 
 
 As at the 30 June 2023 the unaudited net asset value per Ordinary Share, including current 
 period revenue, was 101.78 cents. The Company's factsheet will be located on the Company's 
 website, http://bpcruk.com. 
 
 Dated: 21 July 2023 
 
 Legal Entity Identifier 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVPPUUCMUPWGWG

(END) Dow Jones Newswires

July 21, 2023 11:00 ET (15:00 GMT)

Biopharma Credit (LSE:BPCP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Biopharma Credit
Biopharma Credit (LSE:BPCP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Biopharma Credit